Contributed by NAMPA / AFP.
Press Release from Business Wire: Axonics Modulation Technologies, Inc.
IRVINE, Feb 12, 2019 (BSW) -
Axonics Modulation Technologies, Inc. (NASDAQ: AXNX) a medical
technology company focused on the development and commercialization of
novel implantable Sacral Neuromodulation ("SNM") devices for the
treatment of urinary
and bowel dysfunction, today announced the submission of complete
test data to the U.S. Food & Drug Administration ("FDA") for the purpose
of g ...